Veristat to Acquire Certara’s Regulatory and Medical Writing Business

Contributed by: Business Wire

Logo

Tags

Technology

Biotechnology

Health

Other Health

Consulting

Pharmaceutical

Professional Services

Other Science

Research

Software

General Health

Science

Data Management

Clinical Trials

Veristat

More Like This

Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development

Veristat Acquires Biometrics-focused Instat Clinical Research

Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Gabriela Rosu, MD Senior Director, Global Medical Affairs Veristat (Photo: Business Wire)

Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team

Rachel Page, Chief Commercial Officer, Veristat (Photo: Business Wire)

Veristat Appoints New Chief Commercial Officer

Veristat Launches AI Biostatistics Platform, Cutting Clinical Trial Data Readout Time from 5 Weeks to 5 Days* Without Regulatory Risks

PR Newswire associated0

ESTEVE to acquire TerSera Therapeutics' Infusion Specialty Therapies Business Unit, Expanding U.S. presence